Favorable Long-term Outcomes of Hematopoietic Stem Cell Transplantation for CMML with Myeloablative Conditioning, Anti-thymocyte Globulin, and CD34+ Selected Graft

Παρόμοια τεκμήρια

• CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and anti-thymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse
  ανά: Tamari, Roni, κ.ά.
  Έκδοση: (2015)
• Engraftment Kinetics after Transplantation of Double Unit Cord Blood Grafts Combined with Haplo-identical CD34+ Cells without Anti-thymocyte Globulin
  ανά: Politikos, Ioannis, κ.ά.
  Έκδοση: (2020)
• Impact of Geriatric Vulnerabilities on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Patients with Hematologic Malignancies
  ανά: Lin, Richard J., κ.ά.
  Έκδοση: (2019)
• Frequent Human Herpesvirus-6 Viremia but Low Incidence of Encephalitis in Double-Unit Cord Blood Recipients Transplanted Without Anti-thymocyte Globulin
  ανά: Olson, Amanda L., κ.ά.
  Έκδοση: (2014)
• Low Incidence of GVHD with T-Cell Depleted Allografts Facilitate Further Treatments for Post-Transplantation Relapse in AML and MDS
  ανά: Dahi, Parastoo B., κ.ά.
  Έκδοση: (2016)